Last reviewed · How we verify
NCT05114538
Improving the Part C Early Intervention Service Delivery System for Children With ASD
NA trial testing Reciprocal Imitation Training in Autism Spectrum Disorder in 440 participants. Participants enrolled and being followed up; not accepting new ones.
31 May 2026
Quick facts
| Lead sponsor | University of Washington |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 440 |
| Start date | 27 September 2021 |
| Primary completion | 31 May 2026 |
| Estimated completion | 31 May 2026 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Reciprocal Imitation Training
Conditions studied
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
Sponsor
University of Washington
Who can join
Adults 16 Months to 33 Months, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Despite strong consensus that early, specialized intervention for children with autism spectrum disorder (ASD) can have a dramatic impact on outcomes, the public health system's capacity to provide such services is severely challenged by the rapid rise in ASD prevalence. The goal of this research project is to increase timely and equitable access to ASD-specialized early intervention during the critical first three years of life by capitalizing on the existing infrastructure of the Part C Early Intervention (EI) system, which is publicly funded and available in all states in the United States. This project will train EI providers to use an evidence-based, parent-mediated intervention that can improve child and family outcomes as well as mitigate the long-term substantial economic costs associated with ASD.
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
-
Applying a User-Centered Design Framework to Develop a Remote Research Assessment Protocol for a Randomized Clinical Trial for Toddlers with Early Autism Characteristics.
Tagavi DM, Dai YG, Berger NI, Petruccelli M, et al · · 2025 · cited 4× · PMID 38985370 · DOI 10.1007/s10803-024-06455-7 -
The Language ENvironment Analysis (LENA) System in Toddlers With Early Indicators of Autism: Test-Retest Reliability and Convergent Validity With Clinical Language Assessments.
Nadwodny N, Yoder PJ, Ingersoll BR, Wainer AL, et al · · 2025 · cited 3× · PMID 40452405 · DOI 10.1002/aur.70062 -
Employing user-centered design to develop a remote technology kit for studying young children's social communication skills.
Petruccelli M, Howard M, Morelos A, Wainer A, et al · · 2025 · cited 3× · PMID 39118192 · DOI 10.1093/jpepsy/jsae065 -
A hybrid type I randomized effectiveness-implementation trial of a Naturalistic Developmental Behavioral Intervention in the Part C early intervention system: study protocol.
Wainer AL, Edmunds SR, Carter AS, Stone WL, et al · · 2025 · cited 1× · PMID 40170032 · DOI 10.1186/s12887-025-05587-8 -
Adapting measures of motor imitation for use by caregivers in virtual contexts: Reliability, validity, and sensitivity to change.
Ingersoll B, Howard M, Oosting D, Carter AS, et al · · 2025 · cited 1× · PMID 39569704 · DOI 10.1002/aur.3267 -
Using virtual multiteam systems to conduct a multisite randomized clinical trial in the part C early intervention system: Benefits, challenges, and lessons learned.
Ingersoll B, Espinel A, Nauman J, Broder-Fingert S, et al · · 2024 · cited 1× · PMID 38821261 · DOI 10.1016/j.cct.2024.107585 -
Validating the RISE Communication Play Protocol as a Diagnostic Tool for Autism in Early Childhood: A Pilot Study.
Dai YG, Tagavi DM, Stone WL, Carter AS. · · 2026 · PMID 39843660 · DOI 10.1007/s10803-025-06719-w
Verify or expand the search:
- PubMed search for NCT05114538
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Reciprocal Imitation Training
Trials testing the same drug.
- NCT05880225 — Reciprocal Imitation Training and Musical Rhythm Sensitivity in Autistic Toddlers · NA · recruiting
Other recruiting trials for Autism Spectrum Disorder
Currently open trials in the same condition.
- NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
- NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
- NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting
Other University of Washington trials
Trials by the same sponsor.
- NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
- NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
- NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
- NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
- NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05114538 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Washington
- Last refreshed: 17 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05114538.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing